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CLINICAL STUDY 
Abstract 
 Objective  
 To compare the results of imipenem and meropenem susceptibility testing among multi-
drug resistant (MDR) isolates of Acinetobacter spp. , Pseaudomonas aeruginosa ( P.aeruginosa) 
and members of the Enterobacteriacae.  
Methods  
 Three methods used for susceptibility testing of 210 isolates: disk diffusion (a reference 
method), MicroScan (MicroScan Walk Away 96 System, Dade Behring Inc. West Sacramento 
CA 95691, USA ) and Etest ( AB Biodisk  Solna, Sweden). 
Results 
 Of the 210 isolates, Acinetobacter spp. accounted for the majority of isolates [110(52.4%)] 
followed by P .aeruginosa ,79 (37.6%) . These isolates were more prevalent from respiratory 
specimens 98 (46.7%) ,  Acinetobacter spp. 60(28.6% ) and P.aeruginosa 34(16.2%). The study 
has demonstrated discrepant results for carbapenems tested by MicroScan and Etest . For 
imipenem, the MicroScan exhibited 2.8 % very major error , major error was 10.1% but 3.9% 
by  Etest for Acinetobacter spp. . Other discrepant results (minor errors) were 28.7% and 33% 
for MicroScan and Etest , respectively. For meropenem, minor errors were higher by 
MicroScan (13.6%) and Etest (21%). For P.aeruginosa, very major error (1.6%) was exhibited by 
imipenem Etest but major errors were 23% and 30.5% for both drugs by MicroScan , 
respectively .Minor errors were higher for both drugs by both methods (MicroScan: 15.3% to 
20.8% and Etest : 34.9% to 34.2%).  
Conclusion 
 Microbiology laboratories should consider the use of an additional confirmatory test for 
carbapenem susceptibility testing of clinical isolates of Acinetobacter spp. and P.aeruginosa and 
members of the Enterobacteriacae.   
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Introduction 
 
Carbapenems, such as imipenem and 
PHURSHQHP DUH D FODVV RI ǃ-lactam 
antibiotics with a broadest spectrum of 
DFWLYLW\ FRPSDUHG WR RWKHU ǃ-lactam classes 
in addition of being stable to the typical 
EDFWHULDOǃ-lactamase enzymes1.Until the last 
few years imipenem and meropenem have 
been the most reliable agent for treating 
serious infections caused by MDR 
nosocomial bacteria such as Acinetobacter 
baumannii and P. aeruginosa 2, 3. Although 
carbapenem resistance is mediated by a 
variety of mechanisms, it has been rarely 
reported 4. However , recent reports have 
documented the worldwide emergence of  
clinical isolates of Acinetobacter spp, P. 
aeruginosa and other members of the 
Enterobacteriacae with acquired 
carbapenemases2,5-9 .This has an important 
therapeutic and infection control 
implications as these strains are difficult to 
WUHDW E\ ǃ-lactamase inhibitors and  
resistance can spread widely into various 
Gram negative bacilli . Laboratory detection 
of resistance to carbapenems has been 
reported to be difficult for many reasons; 
low expression of such resistance , 
degradation of the drug , the use of 
automated methods for identification and 
susceptibility testing , in addition to the lack 
of standardized methods of detection 5,10,11. 
Several published reports have documented 
problems of false resistance and false 
susceptibility results with imipenem and 
meropenem while others have shown 
different resistant phenotypes as well as 
errors of various automated systems 
SDUWLFXODUO\ ZKHQ WHVWLQJ ǃ-lactam 
antimicrobial agents among selected Gram 
negative bacteria6,10-13. In this study, we have 
noticed discrepant susceptibility testing 
results (susceptible vs resistant or 
intermediate results) of imipenem and 
meropenem between disc diffusion test and 
the MicroScan system among MDR Gram 
negative bacterial isolates. Due to this 
inherited problem in automated systems in 
testing carbapenems, we compared the 
results of imipenem and meropenem 
susceptibility testing to Etest and the 
MicroScan to determine the degree of 
concordance and discrepancy between  
these applicable methods.                                 
                                                 
Materials and Methods 
 Bacterial isolatesU 
Two hundred and ten non repetitive MDR 
isolates of Enterobacteriacae , Acinetobacter 
spp. and P.aeruginosa were collected during 
the study from August 2006 to  June 2007. 
The isolates were from different clinical 
specimens (respiratory specimens, blood, 
body fluids, tissues urine and different 
swabs) submitted to the microbiology 
laboratory at King Khalid University 
Hospital (KKUH) Riyadh Saudi Arabia. 
KKUH is 850-bedded primary, secondary 
and tertiary hospital serving about two 
million populations.            MDR are isolates 
that are resistant to three or all of the 
following classes of antimicrobialǃ-lactams 
(ceftazidime, cefepim, piperacillin/ 
tazobactam), carbapenems (imipenem, 
meropenem) aminoglycosides (gentamicin 
or amikacin) and fluoroquinolones 
(ciprofloxacin) P14 P. Identification was 
performed by API 20E system updated 
profile (bio Merieux Marcy 1'Etoile, France) 
and by the Micro Scan.                                    
                            
 Inclusion criteriaU 
We included all isolates that had resistance 
to carbapenems in addition to resistance to 
one or more classes of antibiotics during the 
study period.                                                        
 
 Susceptibility testing methodsU  
The MDR isolates were tested for 
susceptibility against imipenem and 
meropenem by the use of three methods: 
disk diffusion, MicroScan, and Etest.  The 
disk diffusion test was performed using 
imipenem and meropenem (10 μg each), 
interpreted according to the Clinical and 
Laboratory Standards Institute (CLSI) P15 P . A 
zone diameter of >16 mm was considered 
sensitive, a zone diameter of 14-15 mm as 
intermediate and <13mm as resistant to both 
antibiotics. Etest was performed on Mueller 
Hinton agar plate according to
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 manufacturer instructions and minimum 
inhibitory concentration (MIC) was 
interpreted according to CLSI criteria 15. An 
MIC of 4-5 μg/l was considered sensitive 
and > 16 μg/l resistant to both antibiotics. 
An MIC reading that fell between twofold 
dilutions was rounded up to the next higher 
twofold dilution as described by the 
manufacturer. The   colonies were 
inoculated into MicroScan Dried Gram 
negative breakpoint Combo Panel types 30 
and Gram negative Combo Panel type 34 
according to manufacturer's protocol. 
Quality control strains used included;  
P.aeruginosa ( ATCC strain 27853) and E.coli 
(ATCC strain 25922).                                          
The antibiogram for other antimicrobial 
agents that did not exhibit any discrepant 
results were not included in the study. 
Characteristics of the type of carbapenem 
resistance is not performed in our laboratory 
                                                                         
  Data analysis  
We calculated the very major and minor 
errors by comparing the testing methods to 
the reference methods using CLSI guidelines 
for verification of in vitro susceptibility 
testing P16P to evaluate the accuracy of the test 
and this parameter was used instead of P-
value in this study. In order to have valid 
calculation of error, it is recommended to 
have at least 35 of resistant isolates for each 
antibiotic P17 Pand in our study; we tested all 
the resistant isolates         during the study 
period. All the applicable statistical                
analysis was performed using SSPS 12.0 
statistical software (SSPS Inc. Wacker Drive, 
Chicago).                                                              
 
Results 
Of the 210 MDR bacterial isolates included 
in this study, 110 (52.4%) were Acinetobacter 
spp. and 79 (37.6%) were P.aeruginosa .The 
rest were different Enterobacteriacae spp.   
isolated in small numbers (Table 1). These 
isolates were more prevalent from 
respiratory tract specimens [98 (46.7%)] 
from where Acinetobacter spp.and 
P.aeruginosa were commonly isolated. These 
included sputum, endotracheal aspirates 
and bronchial wash. Furthermore,  
P.aeruginosa was isolated from 31 (14.8 %) 
swabs followed by Acinetobacter spp. 28 
(13.3%). Swabs included; wounds and other 
screening swabs from different body sites. 
These two organisms have also been 
commonly isolated from urine, blood, body 
fluids, catheter tips and tissues (Table 1). 
The results of susceptibility testing for the 
MDR isolates were tested using Etest and 
MicroScan methods and were compared to 
the disk diffusion (reference method) as 
shown in Table 2. Twenty five isolates of 
the Acinetobacter spp. were susceptible to 
imipenem compared to 16 by Etest and 10 
by MicroScan . Seventy one of Acinetobacter 
spp. isolates were resistant to imipenem by 
disk diffusion compared to 53 and 57 by the 
Etest and the MicroScan, respectively (7 
isolates were not tested by Etest and 2 by the 
MicroScan). Seventy one isolates of 
P.aeruginosa were resistant to imipenem by 
MicroScan. Resistance to meropenem 
among Acinetobacter spp. was similar 
between disk diffusion and Etest (89 isolates 
each) compared to MicroScan (64 isolates) 
while 9 isolates have shown intermediate 
susceptibility to merpenem, 26 isolates were 
so by Etest and 14 isolates by MicroScan. 
Regarding P.aeruginosa , only one isolate 
was susceptible to imipenem by MicroScan 
but 22 isolates were susceptible by disk 
diffusion and 16 isolates by Etest .For 
meropenem, 25  P.aeruginosa isolates were 
resistant to meropenem by disk diffusion  
while 9 isolates were resistant by E test. No 
resistance detected by disk diffusion or Etest 
were detected among other isolates. 
Although a tendency toward carbapenem 
resistance results was noticed when 
Acinetobacter spp. and P.aeruginosa were 
tested by MicroScan, resistance to imipenem 
was much higher for P.aeruginosa by 
MicroScan compared to Acinetobacter spp. 
Conversely, imipenem intermediate 
susceptibility was much lower for 
P.aeruginosa by MicroScan (6 isolates) 
compared to Acinetobacter spp.(41 isolates ). 
Forty seven P.aeruginosa isolates were 
susceptible to meropenem by disk diffusion 
while only 22 isolates were susceptible to 
imipenem. For the other isolates, the 
majority were susceptible to both drugs by
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 disk diffusion and Etest compared to 
MicroScan except for K.pneumoniae where 
two of the three isolates were resistant to 
imipenem by disk diffusion and Etest while 
all were susceptible to meropenem by the 
two methods (not tested by MicroScan) and 
Provedencia spp. were susceptible to both 
drugs by all methods but one isolate was 
resistant to meropenem by MicroScan.  
Considering disk diffusion method as a 
reference, the accuracies of MicroScan and 
Etest for testing carbapenems against MDR 
isolates is shown in Table 3. The result of 
testing Acinetobacter spp. against imipenem 
by MicroScan exhibited 2.8 % very major 
error (false susceptible) compared to 0 % by 
meropenem . For other isolates there was no 
significant difference due to small number 
of isolates tested. Major error (false 
resistant) for Acinetobacter spp. was 10.1% by 
MicroScan while 3.9 % by Etest. There was 
0% major error for meropenem by Etest for 
all isolates. Minor error (any other 
discrepant results with an MIC between 6-16 
μg/l ) was nearly similar for MicroScan and 
Etest, 28.7% and 33% respectively. For 
meropenem, no very major error was 
detected by MicroScan while only 1% by 
Etest.  In contrast, when  Acinetobacter spp 
was tested by Etest it produced no major 
error while 1.94 % rate of major error by 
MicroScan. However, minor error was 
higher by Etest (21%) compared to 
MicroScan (13.6%). For P.aeruginosa, there 
was no very major errors when the bacteria 
was tested by MicroScan for both drugs but 
only for meropenem by Etest while there 
was 1.6% very major error when the 
imipenem was tested by Etest. In contrast, 
major error was exhibited when both 
carbapenems were tested by MicroScan, 23% 
and 30.5%. Minor error was higher for 
imipenem and meropenem (MIC was 
intermediate) when P.aeruginosa was tested 
by Etest (34.9%-34.2%) compared to 
MicroScan (15.3% -20.8%). Regarding other 
isolates, major errors were noticed for 
Enterobacter spp. ,Escherichia coli ( E.coli ) and 
Klabsiella pnaumoniae (K.pneumoniae) , 
55.5%,50% and 33.3% respectively, when 
imipenem was tested by MicroScan and 
57.1% major error for Enterobacter spp. when 
meropenem was tested by Etest but 28.6 % 
minor error when meropenem was tested by 
MicroScan.                                                          
 
Table 1:  Clinical isolates from different clinical sites 
Total 
No (%) 
Tissues
No (%) 
Body 
fluids
No (%)
Blood
No (%)
Catheter 
tips 
No (%) 
Urine
No (%)
Swabs
No (%)
Respiratory
No (%) 
Bacteria
110 
( 52.4)
1 (0.5) 2 (1.0) 2 (1.0) 5 (2.4) 12 (5.7) 28 (13.3)60 (28.6) 
 
 
Acinetobacter 
spp. 
 
79 (37.6) 2 (66.6) 2 (1.0) - 5 (2.4) 5 (2.4) 31 (14.8)34 (16.2) P.aeruginosa 
9 (4.3) ----1 (0.5) 6 (2.9) 2 (1.0) Enterobacter 
spp. 
4 (1.9) ----3 (1.4)  1(0.5) E.coli 
3(1.4) ----3 (1.4) -K.pneumoniae 
2 (1.0) --1(0.5) -1 (0.5) -- Provedencia 
spp. 
2 (1.0) ----1 (0.5) -1 (0.5) Citrobacter spp.
1(0.5) ----1 (0.5) --S. marcescens 
210 (100) 
 
3 (1.4) 4(1.9) 3 (1.4) 10 (4.8) 27 (12.9)65 (31) 98(46.7) Total = 210 
Carbapenems and gram negative rods
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Table 2:  Results of comparison of Etest and MicroScan methods to disk diffusion (reference 
method)   
Meropenem (N)Imipenem (N) 
NT*R I S NT*R I S Methods Bacteria 
 DD** 
Etest 
MicroScan
Acinetobacter spp.
DD** 
Etest 
MicroScan
P. aeruginosa 
 
DD** 
Etest 
MicroScan
Enterobacter spp. 
DD** 
Etest 
MicroScan
E. coli 
DD** 
Etest 
MicroScan
K. pneumonia 
DD** 
Etest 
MicroScan
Provedencia spp. 
 
DD** 
Etest 
MicroScan
Citrobacter spp. 
DD** 
Etest 
MicroScan
S. marcescens 
NT*; not tested, DD**; disk diffusion,   S; sensitive, I; intermediate, R; resistant.
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Table 3:  Accuracy of detecting resistance to carbapenems among Acinetobacter spp., 
P.aeruginosa and common Enterobacteriaecae isolates using disk diffusion as reference 
method                                                                                                                                                              
K.pneumonie
(% error)
E.coli
(%error)
Enterobacter 
spp.(%error) 
P.aeruginosa
(% error)
Acinetobacter 
spp. (% error)
Carbapenems
and  error typeMethods
0 
33.3 
0 
0 
50 
25 
0 
55.5
11.1 
23
15.3 
2.8 
10.1
28.7 
Imipenem
     very major
        major
        minor
MicroScan
NT* 
0 
0 
NT* 
0 
0 
NT* 
57.1
28.6 
0 
30.5 
20.8 
1.94 
13.6 
Meropenem
      very major
        major 
        minor
 
0 
0 
0 
 
0 
25 
0 11.1 
1.6 
0 
34.9 
0 
3.9 
33 
Imipenem
     very major
       major
       minor
Etest 
NT* 
0 
0 
 
NT* 
0 
0 
NT* 
0 
0 34.2
1 
0 
21 
Meropenem
     very major
        major
        minor
NT*; not tested
Discussion 
 
In many diagnostic microbiology 
laboratories use automated systems such as 
the MicroScan for quick identification and 
susceptibility testing of commonly isolated 
bacteria. These systems have many 
advantages including testing large number 
of clinical specimens and decreasing the in-
laboratory turnaround time. However, the 
occurrence of discrepant results of 
susceptibility testing of important 
nosocomial pathogens to carbapenems 
tested by the MicroScan had a serious 
concern for treatment of very ill patients as 
well as the control of dissemination of 
resistance in hospital settings. The results of 
this study have demonstrated that the 
MicroScan has produced discrepant results 
of susceptibility testing among clinically 
significant isolates of Acinetobacter spp. and 
P.aeruginosa and some enteric MDR isolates. 
Imipenem and meropenem Etest results 
have also produced conflicting results for 
Acinetobacter spp. , for imipenem the results 
were closely similar to MicroScan however, 
for meropenem , the results were closely 
similar to disk diffusion .The sensitivity and 
specificity of disk diffusion method could 
not be calculated for two reasons. First, it 
was the reference method. Second, 
sensitivity and specificity of disk diffusion 
method could not be calculated due to 
unavailability in our laboratory of other 
gold standard methods like agar dilution or 
microdilution to compare with. A pseudo-
outbreak of imipenem resistant Acinetobacter 
baumannii has been reported from Greece 
using Vitek automated system while by disk 
diffusion all isolates were defined in the 
susceptible range P8 P. For P.aeruginosa, the 
results of Etest in our study yielded the 
highest discrepant results with imipenem 
and meropenem (34.9% and 34.2 % minor 
errors , respectively). In contrast to our 
results, Steward et al have shown that the 
MicroScan has resulted in 14.8% major error 
and 29.6% minor error when tested 
P.aeruginosa against imipenem P11 P. For 
isolates of Enterobacteriacae , minor errors for 
both carbapenems were observed by agar 
dilution, disk diffusion ,Etest, MicroScan 
and Vitek compared to broth microdilution 
ranged from 1.1% to 8.4% and minor error 
rates were higher for imipenem than for 
meropenem P11 P . The higher percentage of 
errors observed for P.aeruginosa was 
resulted from more isolates of P.aeruginosa
Carbapenems and gram negative rods
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 that had an MIC test results that clustered 
around carbapenem breakpoints than 
members of the Enterobacteriacae P11P. Sader et 
al observed a slight tendency toward more 
resistant results with P.aeruginosa when 
imipenem was tested with the Vitek , 72% 
compared to 68% by MicroScan  and 
consensus ,71% P18. P Moreover, minor error 
was 10 % when P.aeruginosa was tested with 
MicroScan compared to 8% and 11% by 
Vitek 2 and Vitek systems, respectively P18 P. In 
a multicenter laboratory evaluation of 
bioMerieux Vitek system for antimicrobial 
susceptibility testing versus members of the 
family Enterobacteriacaea and P.aeruginosa 
have demonstrated the importance of 
inoculum size as a determinant of the 
accuracy of susceptibility testing results 
with Vitek system i.e. when the inoculum 
density is fourfold higher than the 
recommended by the manufacturer ,high 
rates of false resistance results were 
obtained with cell wall active agents versus 
Enterobacteriacae and P.aeruginosa P10P. Daly et 
al reported that resistance to imipenem 
among P.aeruginosa isolates may be due to 
the zinc concentration in Mueller Hinton 
agar that has been shown to affect that MIC 
of imipenem and susceptibility testing by 
other methods P19P.  In addition P.aeruginosa 
requires higher concentrations of imipenem 
than those required by members of the 
Enterobacteriacae P19P. Regarding other isolates, 
when Enterobacter was tested in our study 
,the number of isolates that have been 
susceptible to imipenem and meropenem by 
disk diffusion have dropped from 9 for both 
drugs and 8 and 9 by Etest  to 3 and 1 by 
MicroScan, respectively .A false susceptible 
results for K.pneumoniae isolates when tested 
carbapenems by MicroScan system was 
reported by Bratu et al which were 
attributed to inoculum size as well  
P
5
P.Although Tenover et al have reported 
variability in detecting imipenem resistance 
among K.pneumoniae with automated 
systems , he also reported that the 
MicroScan and BD Phoenix systems 
produced results that were more consistent 
with reference testing systems than those 
with the Vitek and Sensititre AutoReader 
systems P4P . In agreement with our study, he 
also reported difficulties in determining the 
results with Etest because of the presence of 
colonies within the zones of inhibition and 
disk diffusion was used to confirm 
carbapenem resistance results particularly 
for meropenem in K.pneumoniae isolates P4P  
.Earlier study by O'Rourke et al have 
demonstrated that false resistance to 
imipenem was due in part to the lost of its 
potency by using Sensititre microdilution 
MIC that used custom lots of trays stored at 
room temperature P20 P. Imipenem was 
reported to be stable at -70 P0 P C for up to 1 
year but can deteriorate over time even in a 
pre-dried format stored as recommended by 
the manufacturer P21P. This could be the case 
in our study, although we used an inoculum 
size and storage conditions as 
recommended by the manufacturer. Other 
unknown factors may also be attributed 
under our laboratory conditions. In the 
study by Steward et al ten laboratories 
under-reported imipenem resistance in 
Serratia marcescens (S. marcescens) isolates 
which was due in part to the isolate itself 
where carbapenem resistance in S. 
marcescens is due to different mechanism P11P. 
Other isolates in our study including 
S.marcescens were very few in numbers that 
it may not give an accurate estimation of 
discrepant results. It seems as well that the 
presence of different mechanisms mediating 
resistance to carbapenems among isolates of 
Acinetobacter spp. , P.aeruginosa and selected 
members of the family Enterobacteriacae are 
further attributed to inaccurate detection of 
resistance by microbiology laboratories . 
These mechanisms include impermeability 
,the production of metallo-ǃ-lactamases, 
porin changes and changes in penicillin –
binding proteins that require routine 
screening using different methods such as 
EDTA disk screen or PCR for confirmation 
P
4,6,11
P . Some microbiology laboratories in the 
developing world might not be faced with 
such a problem particularly those that do 
not use the automated systems.                       
                                                          
In conclusion, inaccurate detection of 
carbapenems resistance among Acinetobacter 
spp. and P.aeruginosa and members of the 
family Enterobacteriacae by automated
Hanan Habib et al
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 systems and Etest is worldwide problem. 
We recommend that diagnostic 
microbiology laboratories should be aware 
of the problem and reevaluate their 
susceptibility testing methods and consider 
using an additional nonautomated method 
such as disk diffusion to confirm 
carbapenem nonsusceptibility. Changes in 
susceptibility profiles of many hospital 
pathogens demand the continuous 
improvement of automated systems for 
accurate reading of susceptibility testing 
results.                                                                  
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